Organic Active Ingredients TRIZ Cases

A multilayer transdermal patch incorporates a separate protective layer containing an oxidizing agent to chemically decompose the active medicinal ingredient.

Pyrrolidine derivatives block ERK1 and ERK2 phosphorylation to treat melanoma, pancreatic, thyroid, colorectal, lung, breast, and ovarian cancers.

Segmented administration of insulin glargine, metformin, and exendin-4 reduces HbA1c while minimizing weight gain.

Spiro-lactam compounds modulate NMDA receptors to treat CNS disorders while enabling oral administration.

Synergistic aceclofenac and betamethasone composition delivers potent localized analgesic effects through combined NSAID and corticosteroid mechanisms.

Polyvinyl alcohol binder granulation improves tablet hardness and disintegration time.

A method for producing freeze-dried formulations of amorphous sodium salt using controlled cooling to minimize supercooling.

Merges immunotherapy and chemotherapy to resolve the contradiction between treatment complexity and enhanced reliability.

RNAi constructs targeting CLPTM1L resolve chemotherapeutic resistance by suppressing gene expression, sensitizing cancer cells to apoptosis.

Buffered nicotine chewing gum raises oral cavity pH to accelerate freebase nicotine release, achieving rapid plasma concentration within ten minutes.

Formula I piperidine carbamate compounds act as NR2B selective receptor antagonists to treat depression.

Segmented linkers improve anticancer selectivity while managing structural complexity.

Ammonium and sodium salts of Compound I crystals enhance bioavailability and stability for STING pathway activation.

Compounds bind the TRAF6-Ubc13 interface to reduce NF-kB activation and treat autoimmune diseases.

A green tea extract composition activates bronchial epithelial cell cilia to enhance respiratory defense mechanisms.

CXCL1 protein replaces conventional drugs to promote hair growth without side effects like edema or sexual dysfunction.

Combining c-Met and c-Myc inhibitors overcomes resistance mechanisms while reducing side effects from lower dosages.

Double-stranded ribonucleic acid degrades mRNA transcripts to silence host cell gene expression.

Metal coordination complex binds functional heparin directly to substrates, maintaining anticoagulant activity while eliminating linker complexity.

Extraction of Ganoderma lucidum polysaccharides with molecular weight above 135 kDa to reduce fasting serum insulin and blood glucose levels.

Inhaled interferon-beta bypasses corticosteroid suppression to restore lung antiviral responses.

Ring-opening polymerization synthesizes degradable lipocationic polymers with tertiary amine groups for efficient nucleic acid delivery.

Depleting monocytes and macrophages before lipid nanoparticle administration enhances nucleic acid delivery.

Hemisulfate salt crystalline forms stabilize drug dissolution across varying pH levels.

Amino-substituted heterocyclic compounds selectively inhibit mutant EGFR and HER2 receptors, reducing toxicity to wild-type EGFR.

A recombinant nucleic acid molecule with fragmented translation initiation elements self-splices to produce circular RNA without additional exon sequences.

Replacing ATP-targeting scaffolds with amidine-based structures enables selective SphK1 or SphK2 inhibition while resolving metabolic stability trade-offs.

A polyaphron dispersion enhances dermal diffusion of vitamin D and corticosteroids through a continuous phase.

Spray drying nanocrystal suspensions creates microparticles with controlled size distribution for targeted lung delivery.

Formula I peptide compounds inhibit the NS3 protease, resolving low sustained viral load reduction from interferon and ribavirin therapies.

Triblock copolymers solubilize hydrophobic active agents in aqueous environments through micelle formation.

Surfactants mediate nanoparticle assembly to achieve precise size and shape control, overcoming poor long-range ordering in traditional superlattice synthesis.

Novel compounds of formula I overcome bacterial resistance mechanisms by optimizing molecular parameters to treat infections caused by challenging pathogens.

Editing oligonucleotides utilize phosphonoacetate internucleotide linkages to recruit endogenous ADAR enzymes for targeted RNA deamination.

Tyrosine kinase inhibitors promote lysosomal clearance of heparan sulfate, addressing central nervous system damage in lysosomal storage disorders.

Specific lattice constants and PXRD patterns standardize ABT-869 ethanolate crystalline form 1, resolving characterization complexity during manufacturing.

A pyrazole derivative acts as a selective p38 kinase inhibitor to accelerate recovery from acute exacerbations of chronic obstructive pulmonary disease.

Merging reaction steps into a single vessel maintains continuous chemical transformation, yielding high purity while reducing process complexity.

Fluidized bed process creates spherical safinamide agglomerates for pharmaceutical formulation.

A herbal supplement comprising atractylodes, dandelion root, noni, hesperidin, and quebracho extracts alleviates gastroesophageal reflux disease symptoms.

Targeting the 5-HT1B receptor with agents like vortioxetine resolves slow tissue repair by accelerating wound closure while minimizing scar formation.

Small-molecule LSF inhibitors disrupt tubulin methylation to reduce hepatocellular carcinoma tumorigenesis and metastasis.

Diallyl disulfide stimulates nitrite conversion to nitric oxide, addressing weak biocompatible agents for critical limb ischemia treatment.